Compare ESOA & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ESOA | CDXS |
|---|---|---|
| Founded | 2006 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Water Sewer Pipeline Comm & Power Line Construction | Major Chemicals |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 288.3M | 256.3M |
| IPO Year | 2006 | 2008 |
| Metric | ESOA | CDXS |
|---|---|---|
| Price | $16.24 | $2.20 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $21.00 | N/A |
| AVG Volume (30 Days) | 126.8K | ★ 872.0K |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.74% | N/A |
| EPS Growth | N/A | ★ 43.82 |
| EPS | ★ 0.17 | N/A |
| Revenue | $122,465,826.00 | ★ $138,590,000.00 |
| Revenue This Year | $9.22 | $7.73 |
| Revenue Next Year | $3.77 | $14.24 |
| P/E Ratio | $93.65 | ★ N/A |
| Revenue Growth | 2.74 | ★ 32.30 |
| 52 Week Low | $7.84 | $0.96 |
| 52 Week High | $19.94 | $3.87 |
| Indicator | ESOA | CDXS |
|---|---|---|
| Relative Strength Index (RSI) | 45.39 | 41.84 |
| Support Level | $12.65 | $1.57 |
| Resistance Level | $19.80 | $2.72 |
| Average True Range (ATR) | 0.87 | 0.16 |
| MACD | -0.18 | -0.02 |
| Stochastic Oscillator | 16.99 | 16.10 |
Energy Services of America Corporation is engaged in providing contracting services for energy-related companies. The company is predominantly engaged in the construction, replacement, and repair of natural gas pipelines and storage facilities for utility companies and private natural gas companies. It services the gas, petroleum, power, chemical, and automotive industries and does incidental work such as water and sewer projects. Energy Service's other services include liquid pipeline construction, pump station construction, production facility construction, water and sewer pipeline installations, various maintenance and repair services, and other services related to pipeline construction.
Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.